Legal & General Group PLC Legend Biotech Corp Transaction History

Legal & General Group PLC

$431 Billion
Q3 2025

A detailed history of Legal & General Group PLC transactions in Legend Biotech Corp stock. As of the latest transaction made, Legal & General Group PLC holds 280,791 shares of LEGN stock, worth $8.51 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

280,791

Previous 287,039 2.18%

Holding current value

$8.51 Million

Previous $10.2 Million 10.12%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	SELL	$32.61 - $44.32 $203,747 - $276,911	-6,248 Reduced 2.18%	280,791 $9.16 Million
Q2 2025 Aug 12, 2025	SELL	$27.69 - $37.91 $321,591 - $440,286	-11,614 Reduced 3.89%	287,039 $10.2 Million
Q1 2025 May 15, 2025	SELL	$31.43 - $39.7 $35,264 - $44,543	-1,122 Reduced 0.37%	298,653 $10.1 Million
Q4 2024 Feb 13, 2025	SELL	$32.49 - $50.28 $6.3 Million - $9.75 Million	-193,956 Reduced 39.28%	299,775 $9.75 Million
Q3 2024 Feb 28, 2025	BUY	$43.55 - $59.88 $502,741 - $691,254	11,544 Added 3.85%	311,319 $15.2 Million

Q3 2024 Nov 14, 2024	BUY	$43.55 - $59.88 $636,396 - $875,026	14,613 Added 3.05%	493,731 $24.1 Million
Q2 2024 May 29, 2025	SELL	$39.5 - $57.22 $202,951 - $293,996	-5,138 Reduced 1.67%	302,197 $13.4 Million
Q2 2024 Aug 14, 2024	BUY	$39.5 - $57.22 $2.45 Million - $3.55 Million	62,037 Added 14.87%	479,118 $21.2 Million
Q1 2024 May 29, 2025	BUY	$55.06 - $69.99 $478,030 - $607,653	8,682 Added 2.91%	307,335 $17.2 Million
Q1 2024 May 14, 2024	BUY	$55.06 - $69.99 $36,835 - $46,823	669 Added 0.16%	417,081 $23.4 Million
Q4 2023 May 29, 2025	BUY	$57.25 - $69.74 $458,744 - $558,826	8,013 Added 2.68%	306,666 $18.5 Million
Q4 2023 Feb 15, 2024	BUY	$57.25 - $69.74 $8.04 Million - $9.79 Million	140,361 Added 50.85%	416,412 $25.1 Million
Q3 2023 Nov 14, 2023	SELL	$63.16 - $76.5 $156,194 - $189,184	-2,473 Reduced 0.89%	276,051 $18.5 Million
Q2 2023 Aug 14, 2023	BUY	$46.28 - $75.01 $332,845 - $539,471	7,192 Added 2.65%	278,524 $19.2 Million
Q1 2023 May 15, 2023	BUY	$43.42 - $57.37 $2.04 Million - $2.7 Million	47,021 Added 20.96%	271,332 $13.1 Million
Q4 2022 Feb 14, 2023	BUY	$38.8 - $55.46 $358,977 - $513,115	9,252 Added 4.3%	224,311 $11.2 Million
Q3 2022 Nov 14, 2022	BUY	$38.15 - $57.1 $273,306 - $409,064	7,164 Added 3.45%	215,059 $8.77 Million
Q2 2022 Aug 22, 2022	BUY	$33.54 - $55.0 $916,044 - $1.5 Million	27,312 Added 15.12%	207,895 $11.4 Million
Q1 2022 May 16, 2022	BUY	$31.02 - $48.18 $999,247 - $1.55 Million	32,213 Added 21.71%	180,583 $6.56 Million
Q4 2021 Feb 14, 2022	BUY	$41.14 - $56.98 $6 Million - $8.31 Million	145,891 Added 5885.07%	148,370 $6.92 Million
Q2 2021 Aug 12, 2021	SELL	$25.8 - $41.09 $21,027 - $33,488	-815 Reduced 24.74%	2,479 $102,000
Q4 2020 Feb 12, 2021	BUY	$25.8 - $32.39 $84,985 - $106,692	3,294 New	3,294 $93,000

Others Institutions Holding LEGN

# of Institutions

224

Shares Held

57.2M

Call Options Held

231K

Put Options Held

626K

View Full List

About Legend Biotech Corp

Ticker LEGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 167,403,008
Market Cap $5.07B
Description
Legend Biotech Corporation, a clinical-stage biopharmaceutical company, through its subsidiaries, engages in the discovery and development of novel cell therapies for oncology and other indications in the United States, China, and internationally. Its lead product candidate, LCAR- B38M, is a chimeric antigen receptor for the treatment of multipl...

More about LEGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Legal & General Group PLC, based on Form 13F filings with the SEC.

News

Stay updated on Legal & General Group PLC with notifications on news.

Account

Legal & General Group PLC Legend Biotech Corp Transaction History